• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Dual effects of macrolide antibiotics on rat liver cytochrome P-450. Induction and formation of metabolite-complexes: a structure-activity relationship.

作者信息

Delaforge M, Jaouen M, Mansuy D

出版信息

Biochem Pharmacol. 1983 Aug 1;32(15):2309-18. doi: 10.1016/0006-2952(83)90178-8.

DOI:10.1016/0006-2952(83)90178-8
PMID:6603844
Abstract

Previous studies have shown that the macrolide antibiotics, troleandomycin and erythromycin, are able to induce their own transformation into a metabolite forming an inactivated complex with rat liver cytochrome P-450. This paper reports the results of a study on the effects of several macrolide antibiotics including oleandomycin, erythromycin derivatives, josamycin, methymycin, tylosin, spiramycin and rifampicin, as well as antibiotics of other series, such as tetracycline and lincomycin, on rat liver cytochromes P-450 in vivo and in vitro. Only the antibiotics containing the desosamine and mycaminose amino sugars were able to give the dual effects already found with troleandomycin: induction of cytochrome p-450 and formation of an inhibitory cytochrome P-450--iron--nitrosoalkane metabolite complex in vivo or in vitro. From these studies, it appears that two structural factors are important for a macrolide antibiotic to lead to such effects: the presence of a non-hindered readily accessible N-dimethylamino group and the hydrophobic character of the molecule. These data are discussed in relation to the adverse effects observed during drug associations involving some of these macrolide antibiotics.

摘要

相似文献

1
Dual effects of macrolide antibiotics on rat liver cytochrome P-450. Induction and formation of metabolite-complexes: a structure-activity relationship.
Biochem Pharmacol. 1983 Aug 1;32(15):2309-18. doi: 10.1016/0006-2952(83)90178-8.
2
In vivo and in vitro effects of a new macrolide antibiotic roxithromycin on rat liver cytochrome P-450: comparison with troleandomycin and erythromycin.
Chem Biol Interact. 1988;68(3-4):179-88. doi: 10.1016/0009-2797(88)90015-4.
3
Drug interactions with macrolide antibiotics: specificity of pseudo-suicide inhibition and induction of cytochrome P-450.
Adv Exp Med Biol. 1986;197:155-62. doi: 10.1007/978-1-4684-5134-4_12.
4
Pharmacokinetic drug interactions of macrolides.大环内酯类药物的药代动力学药物相互作用。
Clin Pharmacokinet. 1992 Aug;23(2):106-31. doi: 10.2165/00003088-199223020-00004.
5
Inactivation of cytochrome P-450 by a troleandomycin metabolite. Protective role of glutathione.曲古霉素代谢产物对细胞色素P - 450的灭活作用。谷胱甘肽的保护作用。
J Pharmacol Exp Ther. 1983 Mar;224(3):685-91.
6
Drug interactions and hepatitis produced by some macrolide antibiotics.
J Antimicrob Chemother. 1985 Jul;16 Suppl A:181-94. doi: 10.1093/jac/16.suppl_a.181.
7
Cytochrome P-450 metabolic-intermediate complex formation and induction by macrolide antibiotics; a new class of agents.
Xenobiotica. 1982 Nov;12(11):687-99. doi: 10.3109/00498258209038944.
8
Identification of the cytochrome P-450 induced by macrolide antibiotics in rat liver as the glucocorticoid responsive cytochrome P-450p.鉴定大鼠肝脏中由大环内酯类抗生素诱导产生的细胞色素P-450为糖皮质激素反应性细胞色素P-450p。
Biochemistry. 1985 Apr 23;24(9):2171-8. doi: 10.1021/bi00330a010.
9
Formation of inactive cytochrome P-450 Fe(II)-metabolite complexes with several erythromycin derivatives but not with josamycin and midecamycin in rats.在大鼠体内,几种红霉素衍生物可形成无活性的细胞色素P-450 Fe(II)-代谢物复合物,但交沙霉素和麦迪霉素则不会。
Biochem Pharmacol. 1983 May 1;32(9):1487-93. doi: 10.1016/0006-2952(83)90470-7.
10
Decrease in a constitutive form of cytochrome P-450 by macrolide antibiotics.大环内酯类抗生素导致细胞色素P - 450组成型形式减少。
J Antimicrob Chemother. 1989 Oct;24(4):551-9. doi: 10.1093/jac/24.4.551.

引用本文的文献

1
Insights into Nitrosoalkane Binding to Myoglobin Provided by Crystallography of Wild-Type and Distal Pocket Mutant Derivatives.晶体学研究野生型和远端口袋突变衍生物揭示亚硝烷与肌红蛋白的结合。
Biochemistry. 2023 Apr 18;62(8):1406-1419. doi: 10.1021/acs.biochem.2c00725. Epub 2023 Apr 3.
2
Prediction of potential drug interactions between repurposed COVID-19 and antitubercular drugs: an integrational approach of drug information software and computational techniques data.新冠病毒病(COVID-19)常用药物与抗结核药物之间潜在药物相互作用的预测:药物信息软件与计算技术数据的整合方法
Ther Adv Drug Saf. 2021 Aug 26;12:20420986211041277. doi: 10.1177/20420986211041277. eCollection 2021.
3
Identification of Pharmaceuticals in The Aquatic Environment Using HPLC-ESI-Q-TOF-MS and Elimination of Erythromycin Through Photo-Induced Degradation.
利用高效液相色谱-电喷雾电离-四极杆飞行时间质谱法鉴定水生环境中的药物以及通过光诱导降解消除红霉素
J Vis Exp. 2018 Aug 1(138):57434. doi: 10.3791/57434.
4
Evaluation of Strategies for the Assessment of Drug-Drug Interactions Involving Cytochrome P450 Enzymes.涉及细胞色素P450酶的药物相互作用评估策略的评价
Eur J Drug Metab Pharmacokinet. 2018 Dec;43(6):737-750. doi: 10.1007/s13318-018-0485-7.
5
Quantitative prediction of macrolide drug-drug interaction potential from in vitro studies using testosterone as the human cytochrome P4503A substrate.以睾酮作为人细胞色素P4503A底物,通过体外研究对大环内酯类药物相互作用潜力进行定量预测。
Eur J Clin Pharmacol. 2006 Mar;62(3):203-8. doi: 10.1007/s00228-005-0091-x. Epub 2006 Jan 17.
6
Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs.治疗药物对细胞色素P450 3A4的基于机制的抑制作用。
Clin Pharmacokinet. 2005;44(3):279-304. doi: 10.2165/00003088-200544030-00005.
7
Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.重症监护病房感染治疗的药代动力学方面:聚焦于药物相互作用。
Clin Pharmacokinet. 2001;40(11):833-68. doi: 10.2165/00003088-200140110-00004.
8
Identification of the cytochrome P450 enzymes involved in the metabolism of cisapride: in vitro studies of potential co-medication interactions.鉴定参与西沙必利代谢的细胞色素P450酶:潜在联合用药相互作用的体外研究
Br J Pharmacol. 2000 Apr;129(8):1655-67. doi: 10.1038/sj.bjp.0703246.
9
Inhibition and induction of cytochrome P450 and the clinical implications.细胞色素P450的抑制与诱导及其临床意义。
Clin Pharmacokinet. 1998 Nov;35(5):361-90. doi: 10.2165/00003088-199835050-00003.
10
Cytochrome P-450 complex formation by dirithromycin and other macrolides in rat and human livers.地红霉素及其他大环内酯类药物在大鼠和人肝脏中细胞色素P - 450复合物的形成
Antimicrob Agents Chemother. 1993 Feb;37(2):265-9. doi: 10.1128/AAC.37.2.265.